GlassScriptPhysician profile
Paul Fuchs
NPI 1992708127
$6,869.59
in general payments reported to CMS, 2019-2025
9 companies · $659 in 2025
The $659 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,790 · 2020: $1,977 · 2021: $96.43 · 2022: $31.78 · 2023: $109 · 2024: $207 · 2025: $659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $564 · Travel and Lodging: $326 · Long Term Medical Supply Or Device Loan: $84.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $564.49 |
| Travel and Lodging | $325.71 |
| Long Term Medical Supply Or Device Loan | $84.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Precision Spine, INC. | $5,489.13 | 2019-2020 | |
| Si-Bone, INC. | $362.86 | 2025 | |
| Medtronic USA, INC. | $277.34 | 2019-2020 | |
| Heron Therapeutics, INC. | $231.38 | 2023-2024 | Zynrelef, Aponvie |
| Stryker Corporation | $186.56 | 2025 | Variax, T2 Alpha, Axsos |
| Boston Scientific Corporation | $109.40 | 2025 | Intracept |
| Next Science LLC | $96.43 | 2021 | |
| Baxter Healthcare | $84.71 | 2023 | |
| Radius Health, INC. | $31.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Fuchs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.